Evidence map›Paper›PMID 31623886›Full record

ArticleBiophysical journal2019

Required G

Alan Fabbri, Birgit Goversen, Marc A Vos, Toon A B van Veen, Teun P de Boer

Open access · hybridAbstract read
In one paragraph

Article in Biophysical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Injection of IFrontiers in physiology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Calibration of ionic and cellular cardiac electrophysiology models.Wiley interdisciplinary reviews. Systems biology and medicine · 2020
    Review
  13. Ultrarapid Delayed Rectifier KFrontiers in cell and developmental biology · 2020
    Article
  14. The Heart by Numbers.Biophysical journal · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alan FabbriUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Birgit GoversenUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Marc A VosUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Toon A B van VeenUniversity Medical Center Utrecht, Utrecht, the Netherlands.
Teun P de BoerUniversity Medical Center Utrecht, Utrecht, the Netherlands. Electronic address: t.p.deboer@umcutrecht.nl.
University Medical Center Utrecht · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human-induced pluripotent stem cells derived cardiomyocytes (hiPSC-CMs) are a virtually endless source of human cardiomyocytes that may become a great tool for safety pharmacology; however, their electrical phenotype is immature: they show spontaneous action potentials (APs) and an unstable and depolarized resting membrane potential (RMP) because of lack of I

Indexed as

Models, CardiovascularAction PotentialsInduced Pluripotent Stem CellsMembrane PotentialsMyocytes, CardiacPeptides, Cycliccyclo(cysteinyl-glycyl-aspargyl-seryl-aspargyl-prolyl-lysyl-seryl-cysteine)Peptides, Cyclic

Identifiers

PMID31623886
PMCPMC6990378
OpenAlexW2973147083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.